# IRE (Institut national des Radioéléments)

Source: https://onco.cc/companies/ire/  
OnCo record `ire` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

IRE in Belgium is one of the world's few molybdenum-99 processors, taking irradiated targets from European research reactors, and its IRE ELiT arm makes the Galli Eo gallium-68 generator.

## Summary

The Institut national des Radioéléments at Fleurus processes uranium targets irradiated in BR2, the Petten High Flux Reactor, MARIA and LVR-15 into molybdenum-99 and iodine-131 for generator and radiopharmaceutical makers. Its subsidiary IRE ELiT produces the Galli Eo germanium-68/gallium-68 generator used for PSMA and somatostatin PET and non-carrier-added lutetium-177. It is a Belgian public-interest foundation rather than a listed company.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Also known as: IRE ELiT
- Tags: manufacturing-wave
- HQ: Fleurus
- Type: radiopharma
- Website: https://www.ire.eu

## Sources

- Official website: https://www.ire.eu

## Connected records

- technologies: [Cyclotron isotope production (F-18, Ga-68, Cu-64, Zr-89, At-211)](https://onco.cc/technologies/cyclotron-isotope-production/), [Radionuclide generators and cold kits](https://onco.cc/technologies/radionuclide-generators-kits/), [Research reactors for medical isotopes (Mo-99, Lu-177, I-131)](https://onco.cc/technologies/research-reactor-isotope-production/), [Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225)](https://onco.cc/technologies/therapy-isotope-supply-chain/)

---
JSON: https://onco.cc/api/v1/entities/ire.json